Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-03-18

Clinical Trial Update: Efficacy of Artemether/Lumefantrine for the Treatment of Uncomplicated Malaria. [Phase 4]

View source ↗

Summary

A Phase 4 trial assessed the efficacy of artemether/lumefantrine for uncomplicated Plasmodium falciparum malaria. The study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Artemether-lumefantrine (artemether and lumefantrine)

Snippet

Sponsor: Richard Mwaiswelo | Conditions: Plasmodium Falciparum Malaria | Phase 4 | Status: COMPLETED